[Skip to Content]
[Skip to Content Landing]
April 2016

Targeting the Cancer Moonshot

Author Affiliations
  • 1Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York, New York
  • 2Mailman School of Public Health, Columbia University, New York, New York
  • 3Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University School of Medicine
  • 4Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut

Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA Oncol. 2016;2(4):421-422. doi:10.1001/jamaoncol.2016.0328

Recently, the Obama administration announced the launch of a “moonshot” approach, led by vice president Biden, to finding a cure for cancer and reducing cancer mortality in the United States. Although preliminary communications about the plan mention the development of new vaccines to prevent cancer, the moonshot approach has generally been framed as a search for a cure for cancer, with increased investment in promising therapeutic approaches such as immunotherapy and the creation and sharing of data to simplify the search for personalized medicine and genomic markers that would permit customized therapies.1

First Page Preview View Large
First page PDF preview
First page PDF preview